Ainos (NASDAQ: AIMD) Enters MoU with Merdury to Explore Phase 3 Study of VELDONA
Ainos, Inc. (NASDAQ: AIMD) is engaged as a diversified medical technology company, which is focused on developing innovative point-of-care testing ...
Saturday, March 25, 2023
Tag: HIV treatment
Regnum Corp. (OTC Pink: RGMP) Skyrockets 600% After Entering Into Agreements with CytoDyn (OTCQB: CYDY) and SevenScore Pharmaceuticals to Commercialize HIV Treatment
Regnum Corp. (OTC Pink: RGMP) operates as a biopharma company that focuses on late-stage commercial and clinical development projects. Shares ...
Enochian Biosciences, Inc. (NASDAQ: ENOB) Jumps 107% After FDA Accepts Pre-IND Request for its Potential HIV Break-Through Treatment
Enochian Biosciences, Inc. (NASDAQ: ENOB) is engaged as a biopharmaceutical company, which is focused on the research, development, manufacturing, and ...
GT Biopharma, Inc. (OTCQB: GTBP) Soars 69% After Preclinical Testing of its Tri-Specific Killer Engagers (TriKEs) Were Found to Eliminate HIV-Infected Cells
GT Biopharma, Inc. (OTCQB: GTBP) is engaged as an immune-oncology biotechnology company, which is focused on developing innovative treatments based ...
